Emcure Pharmaceuticals Limited

Company Profile
Company Name Emcure Pharmaceuticals Limited
Open Date 03-07-2024
Close Date 05-07-2024
Exchange BSE, NSE
Lot Size 14 Shares
Issue Price ₹960 to ₹1008 per share
Issue Size 1,93,65,346 shares
Application Amount ₹ 14,112 (14 shares) – 1,97,568 (196 shares)
Recommendation Apply

Incorporated in 1981, Emcure Pharmaceuticals Limited, an Indian pharmaceutical company, develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files. Emcure Pharmaceuticals has 13 manufacturing facilities in India. As of September 30, 2023, the company’s marketing and distribution network in India included over 5,000 stockists, served by 37 carry-and-forward agents. As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India.

(Read more on the review)

Financial Summary in Cr.

KPI’s 2021 2022 Dec-2023
Revenue 5,855.39 5,985.81 6,658.25
EBITDA 1,329.91 1,181.18 1,229.72
Net Profit 702.56 561.85 527.58
RoCE 35.02% 25.21% 19.96%
ROE 35.35% 22.46% 17.87%
P/E 27.53 34.26 36.60

Tentative Timeline

Opening Date 03/07/2024
Closing Date 05-07-2024
Basis of Allotment 08-07-2024
Initiation of Refunds 09-07-2024
Credit of Shares to Demat 09-07-2024
Listing Date 10-07-2024

Objects of the Issue

Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company.
General Corporate Purposes.

Contact Information

Registered Office Emcure Pharmaceuticals Limited Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune -411 057
Phone +91 20 3507 0033
Email investors@emcure.co.in
Website https://www.emcure.com/

Registrar Details

Name Link Intime India Private Ltd
Phone +91-22-4918 6270
Email emcure.ipo@linkintime.co.in
Website https://linkintime.co.in/initial_offer/public-issues.html

IPO Reservation

Anchor Investor Shares Offered 5,779,850 (30.00%)
QIB Shares Offered 3,853,234 (20.00%)
NII (HNI) Shares Offered 2,889,926 (15.00%)
Retail Shares Offered 6,743,160 (35.00%)

Shareholding Pattern

Share Holding Pre Issue (Promoters) 83.21%
Share Holding Post Issue (Promoters) 78.24%

Contact Us to Enable Your Success!